Dibenzocyclooctadiene Lignans from Schisandra chinensis with Anti-Inflammatory Effects

Author:

Rybnikář Michal1,Malaník Milan1ORCID,Šmejkal Karel1ORCID,Švajdlenka Emil1,Shpet Polina12,Babica Pavel2ORCID,Dall’Acqua Stefano3,Smištík Ondřej4,Jurček Ondřej1,Treml Jakub4ORCID

Affiliation:

1. Department of Natural Drugs, Faculty of Pharmacy, Masaryk University, 61200 Brno, Czech Republic

2. Recetox, Faculty of Science, Masaryk University, 62500 Brno, Czech Republic

3. Department of Pharmaceutical and Pharmacological Sciences, University of Padova, 35131 Padua, Italy

4. Department of Molecular Pharmacy, Faculty of Pharmacy, Masaryk University, 61200 Brno, Czech Republic

Abstract

Schisandra chinensis (Schisandraceae) is a medicinal plant widely used in traditional Chinese medicine. Under the name Wu Wei Zi, it is used to treat many diseases, especially as a stimulant, adaptogen, and hepatoprotective. Dibenzocyclooctadiene lignans are the main compounds responsible for the effect of S. chinensis. As a part of ongoing studies to identify and evaluate anti-inflammatory natural compounds, we isolated a series of dibenzocyclooctadiene lignans and evaluated their biological activity. Furthermore, we isolated new sesquiterpene 7,7-dimethyl-11-methylidenespiro[5.5]undec-2-ene-3-carboxylic acid. Selected dibenzocyclooctadiene lignans were tested to assess their anti-inflammatory potential in LPS-stimulated monocytes by monitoring their anti-NF-κB activity, antioxidant activity in CAA assay, and their effect on gap junction intercellular communication in WB-ras cells. Some S. chinensis lignans showed antioxidant activity in CAA mode and affected the gap junction intercellular communication. The anti-inflammatory activity was proven for (−)-gomisin N, (+)-γ-schisandrin, rubrisandrin A, and (−)-gomisin J.

Funder

RECETOX Research Infrastructure

Ministry of Education, Youth and Sports

GAČR

Publisher

MDPI AG

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3